Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells.
<h4>Background</h4>Application of autologous bone marrow mononuclear cells to "no option" patients with advanced critical limb ischemia (CLI) prevented major limb amputation in 73% patients during the 6-month follow-up. We examined which properties of bone marrow stromal cells...
Guardado en:
Autores principales: | Cestmir Altaner, Veronika Altanerova, Marina Cihova, Lubica Hunakova, Katarina Kaiserova, Andrej Klepanec, Ivan Vulev, Juraj Madaric |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9fa8d76075a48b7bb3aef448d7ab53c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Autologous implant of bone marrow mononuclear stem-cells as treatment for equine bicipital tendonitis: case report
por: Menarim,BC, et al.
Publicado: (2012) -
Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.
por: Laurent Spahr, et al.
Publicado: (2013) -
Effect of erythropoietin on bone marrow mononuclear cells
por: A. P. Lykov, et al.
Publicado: (2020) -
Autologous bone marrow cell therapy for peripheral arterial disease
por: Botti C, et al.
Publicado: (2012) -
Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
por: Anne-Laure Leblond, et al.
Publicado: (2009)